Focus: Dornier MedTech is a public medical device company headquartered in France specializing in urology devices, with a focused pipeline in erectile dysfunction, kidney stones, and Peyronie disease treatment.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Cooling — net -8 jobs in 30d
3 added, 11 removed. Slower than typical.
Dornier MedTech is a viable choice for engineers and researchers seeking hands-on device development in a niche urology market, but limited scale and early pipeline maturity mean less career optionality than larger medtech peers.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Dornier MedTech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Dornier MedTech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Importance of precise imaging for stone identification during shockwave lithotripsy: a critical evaluation of "OptiVision" as a post-processing radiography imaging modality.
Control Release Coating for Urinary Catheters with Enhanced Released Profile for Sustained Antimicrobial Protection.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo